Advanced Proteome Therapeutics Corporation announced a non-brokered private placement of 1,450,000 shares at a price of CAD 0.05 per share for gross proceeds of CAD 72,500 to Conation Capital on December 23, 2022. The shares issued will be subject to restrictions on resale expiring on April 24, 2023. The company paid no finders' fees in the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -.--% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 151K | |
+191.37% | 6.97B | |
+5.09% | 1.04B | |
+2.10% | 982M | |
+41.91% | 872M | |
+24.45% | 814M | |
+11.31% | 675M | |
+1.72% | 664M | |
+0.00% | 600M | |
+3.61% | 503M |
- Stock Market
- Equities
- APC.H Stock
- News Advanced Proteome Therapeutics Corporation
- Advanced Proteome Therapeutics Corporation announced that it has received CAD 0.0725 million in funding from Conation Capital